• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[机体对烷化抗肿瘤物质的适应性]

[Adaptation of the body to alkylating anti-tumor substances].

作者信息

Kulik G I, Pel'kis F P, Korol' V I

出版信息

Eksp Onkol. 1989;11(6):34-8.

PMID:2510987
Abstract

It is determined that the organism may adapt in principle to alkylating antitumour preparations, to thiophosphamide in particular, being administered for a long time. The development of cell adaptation reactions in the systems of hemopoiesis and microsomal oxidation of hepatocytes is studied. An increase in the activity of enzymes of the microsomal liver oxidation system is found as accompanied by a lower concentration of 35S-thiophosphamide in the studied tissues and blood serum. The reactivity of tissue and serum SH-groups is observed to decrease with the organism adaptation to the preparation.

摘要

已确定该生物体原则上可能适应长期施用的烷基化抗肿瘤制剂,尤其是硫磷酰胺。研究了造血系统和肝细胞微粒体氧化系统中细胞适应反应的发展。发现微粒体肝氧化系统的酶活性增加,同时所研究的组织和血清中35S-硫磷酰胺的浓度降低。观察到随着生物体对该制剂的适应,组织和血清中SH基团的反应性降低。

相似文献

1
[Adaptation of the body to alkylating anti-tumor substances].[机体对烷化抗肿瘤物质的适应性]
Eksp Onkol. 1989;11(6):34-8.
2
[Hormonal sensitivity of mammary adenocarcinoma in rats and the capacity of the sulfhydryl groups of this tumor for bindig by various antineoplastic drugs].
Vopr Onkol. 1977;23(5):91-4.
3
[Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].[确定肿瘤对烷化剂抗肿瘤制剂个体敏感性方法的实验依据]
Biull Eksp Biol Med. 1969 Dec;68(12):68-70.
4
[Effect of alkylating antitumour preparations on the blood serum SH-groups under clinical and experimental conditions].[临床及实验条件下烷化抗肿瘤制剂对血清巯基的影响]
Vrach Delo. 1966 Sep;9:87-9.
5
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.给药方案对烷化剂体内外细胞毒性的影响。
Cancer Res. 1989 Nov 1;49(21):5994-8.
6
[Modification of the toxic effects of cis-dichlorodiammineplatinum].[顺二氯二氨铂毒性作用的修饰]
Eksp Onkol. 1985;7(6):55-8.
7
Preclinical studies and clinical correlation of the effect of alkylating dose.烷化剂量效应的临床前研究与临床相关性
Cancer Res. 1988 Nov 15;48(22):6417-23.
8
[Genetic differences in mice in the sensitivity to the immunodepressive action of alkylating agents].[小鼠对烷化剂免疫抑制作用敏感性的遗传差异]
Biull Eksp Biol Med. 1983 Apr;95(4):79-81.
9
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.肿瘤对烷化剂的耐药性由仅在体内起作用的机制所致。
Science. 1990 Mar 23;247(4949 Pt 1):1457-61. doi: 10.1126/science.247.4949.1457.
10
Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.药物敏感和耐药的L1210白血病对大剂量化疗的反应。
Cancer Res. 1987 May 1;47(9):2323-7.

引用本文的文献

1
regulatory mutations with driver hallmarks in major cancers.在主要癌症中具有驱动特征的调控突变。
iScience. 2021 Feb 4;24(3):102144. doi: 10.1016/j.isci.2021.102144. eCollection 2021 Mar 19.